chrisvoncsefalvay/vaers-outcomes huggingface dataset:
A few days after taking the vaccine she notice that both of her ears started to get hot and itchy. The itchiness proceeded down to her neck and  back.  She took Benadryl and it went away but came back and got worse. It started spreading throughout her body hives everywhere. She went to the ER and gave her some steroids', Benadryl and peps
around injection site hot; a red spot which is painful, raised, hot, warm, this happened again 1 week later; around injection site painfull; around injection site raised; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (around injection site hot), VACCINATION SITE ERYTHEMA (a red spot which is painful, raised, hot, warm, this happened again 1 week later), VACCINATION SITE PAIN (around injection site painfull) and VACCINATION SITE SWELLING (around injection site raised) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 16-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Jan-2021, the patient experienced VACCINATION SITE WARMTH (around injection site hot), VACCINATION SITE ERYTHEMA (a red spot which is painful, raised, hot, warm, this happened again 1 week later), VACCINATION SITE PAIN (around injection site painfull) and VACCINATION SITE SWELLING (around injection site raised). On 17-Jan-2021, VACCINATION SITE WARMTH (around injection site hot), VACCINATION SITE ERYTHEMA (a red spot which is painful, raised, hot, warm, this happened again 1 week later), VACCINATION SITE PAIN (around injection site painfull) and VACCINATION SITE SWELLING (around injection site raised) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Myalgia, Arthralgia, Fever, NauseaVomiting, arm soreness at injection site Narrative:  Myalgia, arthralgia, nausea, arm soreness at injection site, fever to 101.7
hospitalized for low sodium level (recovered) after food poisoning; low sodium level; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 64 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 19Apr2021 13:00 (Lot number: EW0151) at the age of 64 years as dose 2, single for covid-19 immunisation at Public Health Clinic/Veterans Administration facility. The patient had no known allergies. Relevant medical history included: "Covid-19" (unspecified if ongoing), notes: if covid prior vaccination: Yes; "High blood pressure" (unspecified if ongoing), notes: high blood pressure; "Osteoporosis" (unspecified if ongoing). The patient did not receive any other vaccines within four weeks prior to the vaccination. List of any other medications the patient received within 2 weeks of vaccination included alendronate; lisinopril; multivitamin. Vaccination history included: Bnt162b2 (dose number=1, lot number=ER8733, at 11:00 AM, Left arm), administration date: 29Mar2021, when the patient was 64 years old, for Covid-19 immunization. Since the vaccination, the patient had not been tested for COVID-19. The following information was reported: FOOD POISONING (hospitalization) with onset 27Oct2021, outcome "unknown", described as "hospitalized for low sodium level (recovered) after food poisoning"; BLOOD SODIUM DECREASED (non-serious) with onset 27Oct2021, outcome "recovered" (2021), described as "low sodium level". The patient was hospitalized for food poisoning (start date: 27Oct2021). The patient underwent the following laboratory tests and procedures: blood sodium: (27Oct2021) low, notes: low sodium level. The patient received dose 3 on 19Nov2021.  No follow-up attempts are needed. No further information is expected.
1st vaccine taken at 6 pm on Sunday.  Monday did fine first half of the day. About 12:30 pm, was cleaning a crib at work, had trouble getting up from a squatting position to standing position.  By 3:30 pm, felt horrible - hurt particularly in hip joints, knee joints, also in ankles, and wrists.  Called in to work - took PTO on Tuesday, could not move hips and knees without some assist (on her own), felt like her hips and knees "had rusted."  Felt she had done something very foolish by taking the shot.  Had some severe mental anguish for about 24 hours wondering if this would progress to something more serious (says she was concerned about something like Guillain-Barre Syndrome). Suffered through the night.  Had fever (did not check temperature) and chills.  Was able to get up on Wednesday and it was better.  By 10 am on Wednesday, it was gone.  Had pain, but not swelling at the injection site.  Had to take 2 days PTO days.    2nd vaccine given at about 1:30 pm on a Sunday.  By Sunday evening, chills off and on, fatigue.  Sunday night, when she would sit or lay down, she would feel like she was moving - almost like she was on a boat or had been on a boat, and had a nauseating headache from back of neck and up into her head.  Had alternations of feeling warm and chills. By Tuesday, felt better by 3 pm.  Still feel a little woozy this morning.  Feels like a gentle movement inside like she has been on a boat.  Makes her a little nauseated.  Denies any pain now.  Had pain, but not swelling at the injection site.  Had to take two PTO days..
pt recvd vax; dizziness, numbness of extremities,generalized tremor; sinus tachycardia, fine & gross motor impairment;prednisone x 14 days; sxs persistant at this time;unable to return to work this time;dx:acute post immun encephalomyelitis
This spontaneous report as received from a Register Nurse refers to an unspecified number of unspecified patients of unknown age and gender. Medical history and concurrent conditions were not provided. On an unknown date, the unspecified patients were vaccinated with an unspecified number of doses of improperly stored VARIVAX (Merck), subcutaneously (dose, lot number and expiry date were not reported). No adverse effect reported. There was no concomitant medication provided. Additional information has been requested.
Information has been received from a licensed practical nurse referring to an unspecified number of patients of unknown age and gender. Concurrent conditions and medical history of the patients were not reported. Between the dates of 01-SEP-2015 and 07-OCT-2015, the patients were inadvertently vaccinated with doses of improperly stored M-M-R II (lot # L005290, expiration date 17-FEB-2017 and lot # K018990, expiration date 15-OCT-2016, dose and route unspecified). Other suspect therapies were not reported. No adverse effects were reported. This is one of two reports received from the same source. Additional information has been requested.
This spontaneous case was reported by a consumer and describes the occurrence of ORAL HERPES (Cold Sore), PAIN IN EXTREMITY (sore arm) and HERPES VIRUS INFECTION (herpes outbreak) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016B21A) for COVID-19 vaccination.     The patient's past medical history included Cold sores (Patient experienced the first Cold Sore in 5-6 years.).    On 23-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Mar-2021, the patient experienced ORAL HERPES (Cold Sore), PAIN IN EXTREMITY (sore arm) and HERPES VIRUS INFECTION (herpes outbreak). At the time of the report, ORAL HERPES (Cold Sore), PAIN IN EXTREMITY (sore arm) and HERPES VIRUS INFECTION (herpes outbreak) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided. No concomitant medication was provided.   Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 24-Mar-2021: Patient attached pictures of adverse event.
9/17: he was completely well. 9/18-9/19: may have had some subjective achiness on his body both arms and upper back though nothing localizing 9/19/23 evening:  developed difficulty urinating with retention and some unsteadiness of gait 9/20/23:  Low grade fever at home up to 99.6. Also developed decreased movement of lower legs and some increased weakness feeling in the arms and some subjective sensory changes on the body as well. This led to admission. 9/21-9/23  started on empiric IV Acyclovir 9/22/23 LP on 9/22 showed 145 wbc, protein of 142, glucose of 47. Started on Solu-medrol 1gm IV daily x 5 days. 9/26/23 Pt with "significant quadriplegia," plasma exchanges started every OTHER day x 5 treatments 9/29/23  VDRL is negative. CSF HSV is negative. ANA, ANCA screen neg. MRI C spine showed central spinal cord lesion from C1 to C6 with patchy enhancement. slow progression of the symptoms, enhancement of the lesion, and elevated protein/WBCs in the CSF is more consistent with transverse myelitis.
Fever 101 to 102.8, chills, headache, severe muscle ache low back and neck, nausea, loss appetite, prod cough, just started, some twinges of chest pain.
Localized redness, increased warmth. 5 cm wide by 7 cm long.
20 y/o cauc male primary vaccination with smallpox on 2004Dec22. Patient states that he removed dressing and stopped covering up site for last 3 days. 2 days ago patient noticed multiple vesicles around primary vaccination site which have spread throughout upper left arm. Patient has been wearing long sleeves since immunization and denies close contacts, sharing sheets/bedding/bed. Denies any other vesicles or any sob, cp, n/v, ha, neck stiffness.
She reports her daughter has to use braces and a wheelchair and is unable to work; patient received the Pfizer covid-19 injection on 14Apr2021 and was paralyzed 13 hours later; has to use braces and a wheelchair and is unable to work; her daughter has to use braces and a wheelchair and is unable to work; Does not have full strength in her legs; Left arm goes numb cannot feel hot or cold; Has shortness of breath; Always feels cold; Chest pain; This is a spontaneous report from a contactable consumer (patient's mother). A 33-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection; Lot Number and Expiration date was not reported), via an unspecified route of administration on 14Apr2021 as DOSE NUMBER UNKNOWN, SINGLE for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient experienced the patient has to use braces and a wheelchair and is unable to work, reporter stated here have been other people she is aware of with this same type of reaction, including a girl in (withheld) and a guy in (withheld), patient received the Pfizer covid-19 injection on 14apr2021 and was paralyzed 13 hours later, does not have full strength in her legs, left arm goes numb cannot feel hot or cold, has shortness of breath, always feels cold, chest pain on Apr2021. Patient had been in and out of the hospital and is still having issues 2 months after the Pfizer covid-19 vaccine injection and had been on the local news about her reaction. It was reported that a cardiologist saw "something" on an EKG and patient has also seen a neurologist and several other doctors. The patient underwent lab tests and procedures which included electrocardiogram: unknown in 2021. Clinical outcome of the events was not recovered.  Response: A review of the Prescribing Information (LAB-1457-9.0 Revised: 19May2021) for Pfizer-BioNTech covid-19 vaccine did not find information regarding leg paralysis. As the Prescribing Information does not include all adverse reactions that have been reported or that may occur, please consult with your daughter's doctor/healthcare provider.  Information about lot/batch no has been requested.
Itching on ears, necks and all over body; Pain; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Itching on ears, necks and all over body) and PAIN (Pain) in an 84-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (medical history not reported.).    On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRURITUS (Itching on ears, necks and all over body) and PAIN (Pain). At the time of the report, PRURITUS (Itching on ears, necks and all over body) and PAIN (Pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Reporter did not allow further contact
8/23/2022 4-4:30 Injection site hurt after injection. 8/24/2022@ 10am pt. was practicing soccer, she got dizzy, sat down and her vision got blurry then she experienced a sudden headache that increasingly got worse. 11:15-12 I took her to the ER where her speech was garbled at times. She was weak all over, became slightly nauseous. 12:30 She lost her vision completely for about 1 hour. It started to slowly resolve. IV of NS started, Piggy back of reglan administered. she had a CT of her head which was negative. IV toradol for pain which didn't help. Tylenol 1000mg IV which helped eventually. CBC was  normal, potassium was 3.1, glucose 118, cr/bn10.1.  3:30-4pm She was given kcl 20 meq and fiorecet. By this time she reported it as a normal headache. Needed wheelchair to car and experienced pain getting out of the car which required her having to sit back down and get up slowly after the head pain resolved. She is sleeping
Patient states when she was given the Shingrix vaccine on 4/16/2023 she had a sore arm afterwards. She has no redness or swelling. Her arm is achy when she tries to lift it or move it. She has difficulty sleeping on that arm as well. She has not tried any OTC pain relievers or prescription medications. She has tried to rub and massage that arm with no relief. I mentioned using ice and she is going to try that as well. She went to her doctor for a recent checkup and they had no further recommendations. They stated mostly likely we hit the bone and should use a smaller needle. I told the patient I would follow up with her weekly to see how she is feeling. She is concerned about getting her next vaccine but I said it will be her choice to finish the series.
Difficulty breathing; Fever; Chills; Joints pain; Fatigue; Area of injection pain; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (Difficulty breathing), PYREXIA (Fever), CHILLS (Chills), ARTHRALGIA (Joints pain) and FATIGUE (Fatigue) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029K20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Asthma (Patient is asthmatic.) since an unknown date.    On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Jan-2021, the patient experienced DYSPNOEA (Difficulty breathing), PYREXIA (Fever), CHILLS (Chills), ARTHRALGIA (Joints pain), FATIGUE (Fatigue) and VACCINATION SITE PAIN (Area of injection pain). At the time of the report, DYSPNOEA (Difficulty breathing), PYREXIA (Fever), CHILLS (Chills), ARTHRALGIA (Joints pain), FATIGUE (Fatigue) and VACCINATION SITE PAIN (Area of injection pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Concomitant medication were provided Treatment included Tylenol 500mg, Albuterol
Woke up at 4:20 had sharp pain in heart . At  10 am another sharp pain in heart . Throughout the day sharp pains in heart.
Edema of periorbital, perioral & facial areas w/in several hrs of vax, assoc w/extreme fussiness; rx DPH;
Information has been received from a physician concerning a "16 years old" female who was vaccinated with a third 0.5 ml dose of GARDASIL (lot # not reported) "4-6 months ago". Subsequently the patient fainted after the vaccination. The patient sought an unspecified medical attention. As of 13-MAR-2009, the patient's outcome was unknown. Additional information has been requested.
About 10 minutes after 1st COVID vaccine at clinic, patient reports feeling lightheaded, denies feeling faint. Patient observed for another 30 min. Symptoms resolved. Patient released.
approx 3yrs p/vax pt exp breakthrough varicella w/approx 10 lesions. generally disseminated & pruritic. no further info avail
No additional AE; HCP called to report a TE for VAXNEUVANCE (Lot #W039033; Expiration 10/01/2024; current excursion (49.1F) for 34 minutes; with two previous excursions at (35.9F) for 2 minutes and again at (35.9F) for 2 minutes) which was also administered to a patie; This spontaneous report has been received from a medical assistant, regarding a 22-months-old female patient. The patient's pertinent medical history, previous drug reactions or allergies and concomitant medications were not reported.   On 13-JUN-2023, the patient was vaccinated with an improperly storage dose of pneumococcal 15v conj vaccine (CRM197) (VAXNEUVANCE) injection, once at a dose of 0.5 milliliters in the left thigh as prophylaxis (lot number: W039033, which was determined to be valid for syringe formulation, with an expiration date on 01-OCT-2024) (strength and route of administration were not reported).  The administered dose underwent a temperature excursion of 49.1 degrees Fahrenheit (F) for 34 minutes (product use issue); with two previous excursions at 35.9F for 2 minutes and again at 35.9F for 2 minutes. No additional adverse event was reported.  No additional information was reported.
52 year old healthy female referred from the center for further evaluation of left upper arm erythema, warmth and "burning" pain 6 days following first dose of Moderna COVID-19 vaccine. Pt received vaccine on 05 Jan 2021. She describes some mild tenderness around the injection site and fatigue for 3 days, but no other side effects. NKDA, no seasonal or environmental allergies or previous adverse reactions to vaccines.  On 11 Jan she noticed a tender dime sized area of erythema and induration approx. 10 mm below the injection site. Later that day she had a few more areas of induration both above and below the injection site.
This spontaneous report as received from a medical assistant refers to a patient of unknown age. On 05-MAR-2014, the patient was inadvertently administered PROQUAD, 0.5 ml, subcutaneously (SQ), lot # H015784 that had expired on 24-FEB-2014. No adverse effects reported. Additional information has been requested.
SIRVA; been in pain 11 months; The vaccine was probably injected in the capsule of the joint; The patient is miserable.; This is a spontaneous report received from a contactable reporter(s) (Physician) from medical information team for a Pfizer sponsored program (005570).  A female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history was not reported. There were no concomitant medications. The following information was reported: SHOULDER INJURY RELATED TO VACCINE ADMINISTRATION (non-serious), outcome "unknown", described as "SIRVA"; PAIN (non-serious), outcome "recovering", described as "been in pain 11 months"; PRODUCT ADMINISTERED AT INAPPROPRIATE SITE (non-serious), outcome "unknown", described as "The vaccine was probably injected in the capsule of the joint"; DEPRESSED MOOD (non-serious), outcome "unknown", described as "The patient is miserable.". Therapeutic measures were taken as a result of shoulder injury related to vaccine administration, pain (The patient has had 3 steroid shots and a Medrol dose pack).  Additional information: Patient was suffering from this after getting the Pfizer covid 19 vaccine, she has been in pain for 11 months. The patient was a tall skinny person with skinny arms and the caller thinks the vaccine was injected in the capsule of the joint instead of the deltoid muscle. A couple of days after the dose, the patient started having pain and it got better. The patient has been working with an orthopaedic surgeon in doing therapy. The patient was miserable. The caller believes he reported this event to the CDC a few months ago but does not have a report number. Dates for Shoulder injury related to vaccine administration: (From: Unspecified To: Unspecified). Reporter seriousness for Shoulder injury related to vaccine administration: Unspecified. Reason for no lot number: of Pfizer covid 19 vaccine: Complainant hung up abruptly/transfer incomplete. Expiry date for the Covid-19 vaccine was not provided. Forwarded as an Adverse Event and Medical Inquiry by the Epsilon Escalation team on 19Jan2022. Reporter provided verification of contact address on 18Jan2022. CEP ID #5570 Subject: Patient Assistance, Customer Verbatim: Patient needs treatment options for post Pfizer vaccine SIRVA. Patient has been in pain for 11 months.  The lot number for bnt162b2 was not provided and will be requested during follow up.
Patient with severe soreness, swelling, induration, erythema, and pain in right deltoid region after Pneumovax 23 vaccination. Never before reacted to immunization. No crepitus. Patient was treated with hydrocortisone and subsequent prednisone. Pneumovax was added to allergies.
This spontaneous report was received from a pharmacy intern (also reported as a doctor) referring to a 68 year-old female patient with high blood pressure. She did not have drug/allergy reactions or concomitant medications. On 27-JUL-2016, the patient was vaccinated with ZOSTAVAX. Dose, dose number, route and anatomical location were not reported. On 29-JUL-2016 (reported as within two days), the patient experienced a rash around the injection site as well as muscular pain in the upper arm. The pharmacy intern noted that the patient went to the pharmacy for a check from the pharmacist who recommended to the patient to see her primary care physician. Laboratory test were not performed. At the time of reporting the patient status was reported as ongoing. The causality assessment between the event and the ZOSTAVAX was not reported. Additional information has been requested.
31yo G2P1001 with estimated due date 6/29/2021, pregnancy complicated by diet-controlled gestational diabetes and Crohn's disease. No history of trauma or drug use.  Toxicology screen negative. Normotensive.  Received J&J vaccine 5/17/2021.  2 weeks later (5/31/21), noticed decreased fetal movement and reported to hospital. Immediately upon arrival, developed significant vaginal bleeding. Intrauterine fetal demise and acute placental abruption diagnosed upon arrival to hospital. Delivery by cesarean section per patient request due to her h/o fissures and slow perineal healing with first delivery. At cesarean, complete placental abruption noted with 510g blood clot in retroplacental space.  Postpartum hemorrhage for total of 1,500ml (including the retroplacental clot), requiring Bakri balloon, ICU admission, transfusion of 3u pRBC, 2u FFP, 1pack Platelets.